1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H1, 2016

Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Neuropathic Foot Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Neuropathic Foot Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 40
Abbreviations 40
Definitions 40
Research Methodology 41
Secondary Research 41
About GlobalData 42
Contact Us 42
Disclaimer 42
Source 43

List of Tables
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Region, 2016* 5
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 14
Diabetic Neuropathic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Diabetic Neuropathic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 18
Diabetic Neuropathic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Diabetic Neuropathic Foot Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 13
Diabetic Neuropathic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Diabetic Neuropathic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 17
Diabetic Neuropathic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Diabetic Neuropathic Foot Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 41

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Radiodermatitis Market: - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Radiodermatitis Market: - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

Radiodermatitis, also known as radiation dermatitis, is a significant symptom caused by radiation therapy used in treating cancer as well as exposure to radiation during nuclear disasters. During cance ...

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global phototherapy equipment market is projected to reach USD 583.4 million by 2021, growing at a CAGR of 4.5% during the forecast period of 2016 to 2021. This market is primarily driven by the huge ...

Eczema - Market Insights, Epidemiology and Market Forecast-2023

Eczema - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Eczema - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.